
Gini Fleming
Director, Medical Oncology Breast Program · Pritzker School of Medicine
Credentials: · · · ·
History
- Present
University of Chicago Medical Center · Pritzker School of Medicine
- 1988–1990

Research
Incorporation of bevacizumab in the primary treatment of ovarian cancer
New England Journal of Medicine · 2011 · 1,905 citations
Journal of Clinical Oncology · 2003 · 931 citations
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
New England Journal of Medicine · 2019 · 726 citations

34 papers

20 papers

18 papers

16 papers

14 papers

13 papers

13 papers

13 papers
Grants
- 2014–2019
Alliance for Clinical Trials in Oncology Operations Center
National Cancer Institute · U10
PI · $60.4M · Alliance Nctn Foundation
- 1986–2009
National Cancer Institute · U10
Contact PI · $2.9M · University of Chicago
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $319K · University of Chicago
Clinical trials
- 2013–2027
Assessment of Paclitaxel-Induced Neuropathy
Principal investigator · Active not recruiting
University of Chicago
- 2008–2017
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2007–2010
Principal investigator · Completed · Phase 1
University of Chicago
- 2006–2019
Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)



